144 related articles for article (PubMed ID: 31037438)
1. ASO Author Reflections: Preoperative Pazopanib for High-Risk Soft Tissue Sarcoma: Better Patient Selection is Needed.
Ronellenfitsch U; Hohenberger P
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):602-603. PubMed ID: 31037438
[No Abstract] [Full Text] [Related]
2. Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study.
Nakano K; Motoi N; Inagaki L; Tomomatsu J; Gokita T; Ae K; Tanizawa T; Shimoji T; Matsumoto S; Takahashi S
Jpn J Clin Oncol; 2015 May; 45(5):449-55. PubMed ID: 25724217
[TBL] [Abstract][Full Text] [Related]
3. Pazopanib for metastatic soft-tissue sarcoma.
Endo M; Nielsen TO
Lancet; 2012 Sep; 380(9844):801; author reply 801. PubMed ID: 22939674
[No Abstract] [Full Text] [Related]
4. Pazopanib and the treatment palette for soft-tissue sarcoma.
Bramwell VH
Lancet; 2012 May; 379(9829):1854-6. PubMed ID: 22595798
[No Abstract] [Full Text] [Related]
5. Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04).
Ronellenfitsch U; Karampinis I; Dimitrakopoulou-Strauss A; Sachpekidis C; Jakob J; Kasper B; Nowak K; Pilz L; Attenberger U; Gaiser T; Derigs HG; Schwarzbach M; Hohenberger P
Ann Surg Oncol; 2019 May; 26(5):1332-1339. PubMed ID: 30843160
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial.
Karch A; Koch A; Grünwald V
Trials; 2016 Jul; 17(1):312. PubMed ID: 27387325
[TBL] [Abstract][Full Text] [Related]
7. Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
Nakano K; Inagaki L; Tomomatsu J; Motoi N; Gokita T; Ae K; Tanizawa T; Shimoji T; Matsumoto S; Takahashi S
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):357. PubMed ID: 24630810
[No Abstract] [Full Text] [Related]
8. A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.
Alavi SN; Florou V; Tinoco G; Trent JC; Wilky BA
Discov Med; 2018 Mar; 25(137):131-144. PubMed ID: 29641974
[TBL] [Abstract][Full Text] [Related]
9. Fatal heart failure in a young adult female sarcoma patient treated with pazopanib.
Soomers VLMN; Desar IME; van Erp NP; Verwiel J; Kaal SEJ; van der Graaf WTA
Acta Oncol; 2017 Sep; 56(9):1233-1234. PubMed ID: 28537442
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Preoperative Biopsy for Retroperitoneal Sarcoma.
Straker RJ; Karakousis GC
Ann Surg Oncol; 2021 Oct; 28(11):6880-6881. PubMed ID: 33638039
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Radiation Therapy in Soft Tissue Sarcoma: Who Benefits and How?
Albertsmeier M; Roeder F; Angele MK
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):934-935. PubMed ID: 30374920
[No Abstract] [Full Text] [Related]
12. Pazopanib for patients with advanced soft tissue sarcomas in a real-life setting.
Sleijfer S
Cancer; 2016 May; 122(9):1346-8. PubMed ID: 26970270
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Evolving Concepts for Radiation Therapy in Extremity and Trunk Soft Tissue Sarcoma.
Fiore M; Gronchi A
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):942-943. PubMed ID: 30421054
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma.
Haas RL; Szkandera J
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):924-925. PubMed ID: 30298310
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Chemoradiation for High-Risk Soft Tissue Sarcomas.
Lu E; Ryan CW
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):938-939. PubMed ID: 30367302
[No Abstract] [Full Text] [Related]
16. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Minimally Invasive Surgery for Retroperitoneal Soft Tissue Sarcoma.
Gani F; Johnston FM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):604-605. PubMed ID: 31054039
[No Abstract] [Full Text] [Related]
18. [Pazopanib (Votrient) in the management of renal cell cancer and soft tissue sarcomas].
Gennigens C; Jerusalem G
Rev Med Liege; 2012; 67(7-8):437-42. PubMed ID: 22984765
[TBL] [Abstract][Full Text] [Related]
19. A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.
Haas RL; Gelderblom H; Sleijfer S; van Boven HH; Scholten A; Dewit L; Borst G; van der Hage J; Kerst JM; Nout RA; Hartgrink HH; de Pree I; Verhoef C; Steeghs N; van Coevorden F
Acta Oncol; 2015; 54(8):1195-201. PubMed ID: 25920360
[TBL] [Abstract][Full Text] [Related]
20. Pazopanib efficacy and toxicity in a metastatic sarcoma cohort: Are Indian patients different?
Sharma A; Vanidassane I; Aggarwal A; Mridha AR; Pandey R; Dhamija E; Barwad A; Rastogi S
Indian J Cancer; 2019; 56(3):207-210. PubMed ID: 31389382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
